Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
In8bio initiated with a Buy at Mizuho » 08:53
08/24/21
08/24
08:53
08/24/21
08:53
INAB

In8bio

$8.02 /

+0.38 (+4.97%)

Mizuho analyst Mara…

Mizuho analyst Mara Goldstein initiated coverage of In8bio with a Buy rating and $12 price target.

ShowHide Related Items >><<
INAB In8bio
$8.02 /

+0.38 (+4.97%)

INAB In8bio
$8.02 /

+0.38 (+4.97%)

08/23/21 B. Riley
In8bio initiated with a Buy on cancer potential at B. Riley
08/23/21 B. Riley
In8bio initiated with a Buy at B. Riley
  • 30
    Jul
  • 13
    Nov
INAB In8bio
$8.02 /

+0.38 (+4.97%)

Initiation
In8bio initiated with a Buy on cancer potential at B. Riley » 08:10
08/23/21
08/23
08:10
08/23/21
08:10
INAB

In8bio

$7.64 /

-0.22 (-2.80%)

B. Riley analyst Kalpit…

B. Riley analyst Kalpit Patel initiated coverage of In8bio with a Buy rating and $19 price target. IN8bio is clinical-stage biotech company focused exclusively on advancing gamma-delta T cells as a potential option for difficult-to-treat cancers, Patel tells investors in a research note. The analyst believes gamma-delta T cells are likely the ideal source of cells for attacking solid tumors and that the company's management has implemented a rational strategy to tackle glioblastoma multiforme.

ShowHide Related Items >><<
INAB In8bio
$7.64 /

-0.22 (-2.80%)

INAB In8bio
$7.64 /

-0.22 (-2.80%)

08/23/21 B. Riley
In8bio initiated with a Buy at B. Riley
  • 30
    Jul
  • 13
    Nov
INAB In8bio
$7.64 /

-0.22 (-2.80%)

Initiation
In8bio initiated with a Buy at B. Riley » 05:10
08/23/21
08/23
05:10
08/23/21
05:10
INAB

In8bio

$7.64 /

-0.22 (-2.80%)

B. Riley initiated…

B. Riley initiated coverage of In8bio with a Buy rating and $19 price target.

ShowHide Related Items >><<
INAB In8bio
$7.64 /

-0.22 (-2.80%)

  • 30
    Jul
  • 13
    Nov
INAB In8bio
$7.64 /

-0.22 (-2.80%)

On The Fly
Opening Day: Sportradar files for IPO after SPAC talks break off » 08:27
08/21/21
08/21
08:27
08/21/21
08:27
ARBK

Argo Blockchain

/

+

, ARBKF

Argo Blockchain

$1.83 /

+0.15 (+8.93%)

, PRCT

Procept BioRobotics

/

+

, SRAD

Sportradar

/

+

, QNIU

Qiniu

/

+

, CMSL

Camposol

/

+

, SPRK

Spark Education

/

+

, SCAN

Perspectum Group

/

+

, AUTH

Authentic Brands Group

$8.01 /

+ (+0.00%)

, BLK

BlackRock

$917.42 /

+14.44 (+1.60%)

, SPG

Simon Property

$128.78 /

+0.35 (+0.27%)

, MS

Morgan Stanley

$100.71 /

+1.01 (+1.01%)

, GS

Goldman Sachs

$396.03 /

+2.76 (+0.70%)

, BCS

Barclays

$9.96 /

+0.01 (+0.10%)

, BAC

Bank of America

$40.38 /

+0.195 (+0.49%)

, MXCT

MaxCyte

$14.39 /

+0.61 (+4.43%)

, RXST

RxSight

$11.89 /

-0.175 (-1.45%)

, TNYA

Tenaya Therapeutics

$22.31 /

+1.41 (+6.75%)

, RANI

Rani Therapeutics

$16.11 /

-0.93 (-5.46%)

, NUVL

Nuvalent

$27.21 /

+0.44 (+1.64%)

, ICVX

Icosavax

$34.69 /

+0.69 (+2.03%)

, RSKD

Riskified

$28.61 /

+1.445 (+5.32%)

, OMGA

Omega Therapeutics

$21.94 /

-0.09 (-0.41%)

, IMRX

Immuneering

$30.23 /

-0.53 (-1.72%)

, INAB

In8bio

$7.64 /

-0.22 (-2.80%)

, HOOD

Robinhood

$42.62 /

-1.99 (-4.46%)

, RLYB

Rallybio

$12.57 /

-0.23 (-1.80%)

, ABVC

ABVC BioPharma

$2.03 /

-0.12 (-5.58%)

In a quiet week for IPOs,…

ShowHide Related Items >><<
SPG Simon Property
$128.78 /

+0.35 (+0.27%)

RLYB Rallybio
$12.57 /

-0.23 (-1.80%)

MXCT MaxCyte
$14.39 /

+0.61 (+4.43%)

MS Morgan Stanley
$100.71 /

+1.01 (+1.01%)

INAB In8bio
$7.64 /

-0.22 (-2.80%)

ICVX Icosavax
$34.69 /

+0.69 (+2.03%)

HOOD Robinhood
$42.62 /

-1.99 (-4.46%)

GS Goldman Sachs
$396.03 /

+2.76 (+0.70%)

BLK BlackRock
$917.42 /

+14.44 (+1.60%)

BCS Barclays
$9.96 /

+0.01 (+0.10%)

BAC Bank of America
$40.38 /

+0.195 (+0.49%)

AUTH Authentic Brands Group
$8.01 /

+ (+0.00%)

ARBK Argo Blockchain
/

+

ARBKF Argo Blockchain
$1.83 /

+0.15 (+8.93%)

06/01/21 H.C. Wainwright
Argo Blockchain initiated with a Buy at H.C. Wainwright
PRCT Procept BioRobotics
/

+

SRAD Sportradar
/

+

QNIU Qiniu
/

+

CMSL Camposol
/

+

SPRK Spark Education
/

+

SCAN Perspectum Group
/

+

AUTH Authentic Brands Group
$8.01 /

+ (+0.00%)

BLK BlackRock
$917.42 /

+14.44 (+1.60%)

07/15/21 Credit Suisse
BlackRock price target lowered to $1,000 from $1,011 at Credit Suisse
07/15/21 Argus
BlackRock price target raised to $975 from $950 at Argus
07/15/21 Deutsche Bank
BlackRock price target lowered to $1,001 from $1,018 at Deutsche Bank
07/15/21 BMO Capital
BlackRock price target raised to $803 from $773 at BMO Capital
SPG Simon Property
$128.78 /

+0.35 (+0.27%)

08/16/21 Truist
Simon Property price target raised to $136 from $130 at Truist
08/13/21 Truist
Simon Property price target raised to $136 from $130 at Truist
08/13/21 Morgan Stanley
Simon Property price target raised to $161 from $150 at Morgan Stanley
08/04/21 BofA
Simon Property upgraded to Buy from Neutral at BofA
MS Morgan Stanley
$100.71 /

+1.01 (+1.01%)

08/13/21 Seaport Global
Morgan Stanley downgraded to Neutral at Seaport Global on valuation
08/13/21 Seaport Global
Morgan Stanley downgraded to Neutral from Buy at Seaport Global
07/19/21 Citi
Morgan Stanley price target raised to $97 from $88 at Citi
07/16/21 Argus
Morgan Stanley price target raised to $105 from $93 at Argus
GS Goldman Sachs
$396.03 /

+2.76 (+0.70%)

07/14/21 Oppenheimer
Goldman Sachs price target raised to $540 from $493 at Oppenheimer
07/14/21 Credit Suisse
Goldman Sachs price target raised to $425 from $420 at Credit Suisse
07/14/21 Mizuho
Affirm selloff on Apple competition fears overblown, says Mizuho
07/14/21 Piper Sandler
Goldman Sachs price target raised to $435 from $420 at Piper Sandler
BCS Barclays
$9.96 /

+0.01 (+0.10%)

08/02/21 RBC Capital
Barclays price target raised to 190 GBp from 180 GBp at RBC Capital
07/30/21 Morgan Stanley
Barclays price target raised to 205 GBp from 200 GBp at Morgan Stanley
07/29/21 UBS
Barclays price target raised to 220 GBp from 210 GBp at UBS
07/29/21 Deutsche Bank
Barclays price target raised to 240 GBp from 230 GBp at Deutsche Bank
BAC Bank of America
$40.38 /

+0.195 (+0.49%)

07/19/21 Odeon Capital
Bank of America downgraded to Hold from Buy at Odeon Capital
07/06/21 Keefe Bruyette
Bank of America assumed with a Market Perform at Keefe Bruyette
06/02/21 Truist
Bank of America initiated with a Buy at Truist
05/04/21
Fly Intel: Top five analyst downgrades
MXCT MaxCyte
$14.39 /

+0.61 (+4.43%)

RXST RxSight
$11.89 /

-0.175 (-1.45%)

TNYA Tenaya Therapeutics
$22.31 /

+1.41 (+6.75%)

RANI Rani Therapeutics
$16.11 /

-0.93 (-5.46%)

NUVL Nuvalent
$27.21 /

+0.44 (+1.64%)

ICVX Icosavax
$34.69 /

+0.69 (+2.03%)

RSKD Riskified
$28.61 /

+1.445 (+5.32%)

OMGA Omega Therapeutics
$21.94 /

-0.09 (-0.41%)

IMRX Immuneering
$30.23 /

-0.53 (-1.72%)

INAB In8bio
$7.64 /

-0.22 (-2.80%)

HOOD Robinhood
$42.62 /

-1.99 (-4.46%)

08/17/21 Redburn
Redburn starts Robinhood at Buy with fair value implying 29% upside
08/17/21 Redburn
Robinhood initiated with a Buy at Redburn
08/05/21 Wolfe Research
Robinhood initiated with a Peer Perform at Wolfe Research
07/29/21
Fly Intel: Top five analyst initiations
RLYB Rallybio
$12.57 /

-0.23 (-1.80%)

ABVC ABVC BioPharma
$2.03 /

-0.12 (-5.58%)

SPG Simon Property
$128.78 /

+0.35 (+0.27%)

MS Morgan Stanley
$100.71 /

+1.01 (+1.01%)

HOOD Robinhood
$42.62 /

-1.99 (-4.46%)

GS Goldman Sachs
$396.03 /

+2.76 (+0.70%)

BLK BlackRock
$917.42 /

+14.44 (+1.60%)

BCS Barclays
$9.96 /

+0.01 (+0.10%)

BAC Bank of America
$40.38 /

+0.195 (+0.49%)

ABVC ABVC BioPharma
$2.03 /

-0.12 (-5.58%)

  • 30
    Jul
  • 30
    Jul
  • 30
    Jul
  • 30
    Jul
  • 29
    Jul
  • 30
    Jul
  • 30
    Jul
  • 29
    Jul
  • 30
    Jul
  • 29
    Jul
  • 29
    Jul
  • 29
    Jul
  • 16
    Jul
  • 19
    Nov
  • 13
    Nov
SRAD Sportradar
/

+

MS Morgan Stanley
$100.71 /

+1.01 (+1.01%)

HOOD Robinhood
$42.62 /

-1.99 (-4.46%)

GS Goldman Sachs
$396.03 /

+2.76 (+0.70%)

BLK BlackRock
$917.42 /

+14.44 (+1.60%)

BCS Barclays
$9.96 /

+0.01 (+0.10%)

BAC Bank of America
$40.38 /

+0.195 (+0.49%)

AUTH Authentic Brands Group
$8.01 /

+ (+0.00%)

SRAD Sportradar
/

+

SPG Simon Property
$128.78 /

+0.35 (+0.27%)

RXST RxSight
$11.89 /

-0.175 (-1.45%)

QNIU Qiniu
/

+

HOOD Robinhood
$42.62 /

-1.99 (-4.46%)

GS Goldman Sachs
$396.03 /

+2.76 (+0.70%)

AUTH Authentic Brands Group
$8.01 /

+ (+0.00%)

SPG Simon Property
$128.78 /

+0.35 (+0.27%)

MS Morgan Stanley
$100.71 /

+1.01 (+1.01%)

HOOD Robinhood
$42.62 /

-1.99 (-4.46%)

GS Goldman Sachs
$396.03 /

+2.76 (+0.70%)

BAC Bank of America
$40.38 /

+0.195 (+0.49%)

Hot Stocks
In8bio completes dosing of first cohort in Phase 2 trial with Allogeneic » 08:18
08/11/21
08/11
08:18
08/11/21
08:18
INAB

In8bio

$9.80 /

-0.01 (-0.10%)

IN8bio announced…

IN8bio announced completion of dosing of the first patient cohort in a Phase 1 clinical trial of INB-100, a donor-derived gamma-delta T cell therapeutic in development for patients with leukemia undergoing haploidentical stem cell transplant. The three patients comprising the first cohort did not experience any severe adverse infusion reactions or dose limiting toxicities to date. The first two patients are at 14.5 months and 12.2 months, respectively, post-HSCT as of June 30, 2021, and continue to be in complete remission. "For patients with high-risk leukemia, the availability of HSCT is a path toward a potential cure, but rates of leukemic relapse remain high," said William Ho, Chief Executive Officer and co-founder of IN8bio. "Research by our Chief Scientific Officer, Dr. Lamb, and others has shown that that high numbers of circulating gamma-delta T cells have been correlated with improved survival outcomes in these patients. Our goal with INB-100 is to generate an anti-leukemic effect by supplementing patients' immune systems with allogeneic gamma-delta T cells to reduce relapse and improve overall survival in patients who have undergone an allogeneic HSCT. Although early, we are encouraged by data obtained to date indicating the potential for well-tolerated allogeneic gamma delta T-cell therapies. We look forward to announcing additional data on this program in 2022."

ShowHide Related Items >><<
INAB In8bio
$9.80 /

-0.01 (-0.10%)

  • 30
    Jul
  • 13
    Nov
INAB In8bio
$9.80 /

-0.01 (-0.10%)

Hot Stocks
In8bio appoints Fairbairn and Greenwood to board of directors » 08:23
08/04/21
08/04
08:23
08/04/21
08:23
INAB

In8bio

$9.95 /

-0.05 (-0.50%)

IN8bio announces the…

IN8bio announces the appointments of Emily Fairbairn and Luba Greenwood as new members of its Board of Directors. Fairbairn is currently a principal of Transcend Partners and was co-founder and CEO of Ascend Capital for nearly 20 years. Greenwood serves as Managing Partner of Binney Street Capital and co-founded and is currently CEO of LUCA Biologics. Fairbairn will be serving on the nomination and corporate governance committee, while Greenwood will be serving on the audit and compensation committees. Their terms will both expire at the annual meeting of stockholders to be held in 2022.

ShowHide Related Items >><<
  • 30
    Jul
  • 13
    Nov
INAB In8bio
$9.95 /

-0.05 (-0.50%)

On The Fly
Opening Day: Robinhood shares fall after IPO » 08:53
07/31/21
07/31
08:53
07/31/21
08:53
MXCT

MaxCyte

$16.89 /

-0.11 (-0.65%)

, RXST

RxSight

$16.42 /

-1.33 (-7.49%)

, TNYA

Tenaya Therapeutics

$15.75 /

-3.94 (-20.01%)

, RANI

Rani Therapeutics

$10.95 /

-0.37 (-3.27%)

, OMGA

Omega Therapeutics

$16.05 /

-4.43 (-21.63%)

, IMRX

Immuneering

$17.72 /

-1.94 (-9.87%)

, INAB

In8bio

$10.01 /

-0.13 (-1.28%)

, DOLE

Dole

$14.55 /

-0.65 (-4.28%)

, HOOD

Robinhood

$35.57 /

+0.75 (+2.15%)

, NUVL

Nuvalent

$18.42 /

-0.39 (-2.07%)

, ICVX

Icosavax

$25.00 /

-8.68 (-25.77%)

, RSKD

Riskified

$27.18 /

+0.99 (+3.78%)

, COOK

Traeger

$22.21 /

+0.2 (+0.91%)

, RLYB

Rallybio

$17.42 /

+3.02 (+20.97%)

, DUOL

Duolingo

$140.08 /

+3.13 (+2.29%)

, MLNK

MeridianLink

$23.90 /

-0.63 (-2.57%)

, PWSC

PowerSchool

$18.49 /

+0.02 (+0.11%)

, CADL

Candel Therapeutics

$7.63 /

+0.06 (+0.79%)

, SNTG

Sentage

$5.36 /

+0.55 (+11.43%)

, RNAZ

Transcode Therapeutics

$2.96 /

+0.035 (+1.20%)

, AGRI

AgriFORCE Growing Systems

$3.42 /

+0.32 (+10.32%)

, MITQ

Moving iMage

$3.89 /

-0.1 (-2.51%)

, IINN

Inspira Technologies

$3.88 /

-0.05 (-1.27%)

, UNCY

Unicycive Therapeutics

$2.76 /

-0.05 (-1.78%)

, SPRK

Spark Education

/

+

, QNIU

Qiniu

/

+

, CMSL

Camposol

/

+

, SCAN

Perspectum Group

/

+

, AUTH

Authentic Brands Group

$8.01 /

+ (+0.00%)

, MS

Morgan Stanley

$95.97 /

-0.295 (-0.31%)

, GS

Goldman Sachs

$375.04 /

-2.43 (-0.64%)

, BCS

Barclays

$9.78 /

-0.18 (-1.81%)

, BAC

Bank of America

$38.35 /

-0.335 (-0.87%)

, BLK

BlackRock

$867.23 /

-1.6 (-0.18%)

, SPG

Simon Property

$126.52 /

+0.63 (+0.50%)

Shares of Robinhood…

ShowHide Related Items >><<
SPG Simon Property
$126.52 /

+0.63 (+0.50%)

RLYB Rallybio
$17.42 /

+3.02 (+20.97%)

MS Morgan Stanley
$95.97 /

-0.295 (-0.31%)

MITQ Moving iMage
$3.89 /

-0.1 (-2.51%)

HOOD Robinhood
$35.57 /

+0.75 (+2.15%)

GS Goldman Sachs
$375.04 /

-2.43 (-0.64%)

BLK BlackRock
$867.23 /

-1.6 (-0.18%)

BCS Barclays
$9.78 /

-0.18 (-1.81%)

BAC Bank of America
$38.35 /

-0.335 (-0.87%)

AGRI AgriFORCE Growing Systems
$3.42 /

+0.32 (+10.32%)

MXCT MaxCyte
$16.89 /

-0.11 (-0.65%)

RXST RxSight
$16.42 /

-1.33 (-7.49%)

TNYA Tenaya Therapeutics
$15.75 /

-3.94 (-20.01%)

RANI Rani Therapeutics
$10.95 /

-0.37 (-3.27%)

OMGA Omega Therapeutics
$16.05 /

-4.43 (-21.63%)

IMRX Immuneering
$17.72 /

-1.94 (-9.87%)

INAB In8bio
$10.01 /

-0.13 (-1.28%)

DOLE Dole
$14.55 /

-0.65 (-4.28%)

HOOD Robinhood
$35.57 /

+0.75 (+2.15%)

07/29/21
Fly Intel: Top five analyst initiations
07/29/21 Atlantic Equities
Robinhood initiated with an Overweight at Atlantic Equities
NUVL Nuvalent
$18.42 /

-0.39 (-2.07%)

ICVX Icosavax
$25.00 /

-8.68 (-25.77%)

RSKD Riskified
$27.18 /

+0.99 (+3.78%)

COOK Traeger
$22.21 /

+0.2 (+0.91%)

RLYB Rallybio
$17.42 /

+3.02 (+20.97%)

DUOL Duolingo
$140.08 /

+3.13 (+2.29%)

MLNK MeridianLink
$23.90 /

-0.63 (-2.57%)

PWSC PowerSchool
$18.49 /

+0.02 (+0.11%)

CADL Candel Therapeutics
$7.63 /

+0.06 (+0.79%)

SNTG Sentage
$5.36 /

+0.55 (+11.43%)

RNAZ Transcode Therapeutics
$2.96 /

+0.035 (+1.20%)

AGRI AgriFORCE Growing Systems
$3.42 /

+0.32 (+10.32%)

MITQ Moving iMage
$3.89 /

-0.1 (-2.51%)

IINN Inspira Technologies
$3.88 /

-0.05 (-1.27%)

UNCY Unicycive Therapeutics
$2.76 /

-0.05 (-1.78%)

SPRK Spark Education
/

+

QNIU Qiniu
/

+

CMSL Camposol
/

+

SCAN Perspectum Group
/

+

AUTH Authentic Brands Group
$8.01 /

+ (+0.00%)

MS Morgan Stanley
$95.97 /

-0.295 (-0.31%)

07/19/21 Citi
Morgan Stanley price target raised to $97 from $88 at Citi
07/16/21 Argus
Morgan Stanley price target raised to $105 from $93 at Argus
07/16/21 BMO Capital
Morgan Stanley price target raised to $103 from $97 at BMO Capital
07/16/21 Piper Sandler
Morgan Stanley price target raised to $100 from $93 at Piper Sandler
GS Goldman Sachs
$375.04 /

-2.43 (-0.64%)

07/14/21 Oppenheimer
Goldman Sachs price target raised to $540 from $493 at Oppenheimer
07/14/21 Credit Suisse
Goldman Sachs price target raised to $425 from $420 at Credit Suisse
07/14/21 Mizuho
Affirm selloff on Apple competition fears overblown, says Mizuho
07/14/21 Piper Sandler
Goldman Sachs price target raised to $435 from $420 at Piper Sandler
BCS Barclays
$9.78 /

-0.18 (-1.81%)

07/30/21 Morgan Stanley
Barclays price target raised to 205 GBp from 200 GBp at Morgan Stanley
07/29/21 UBS
Barclays price target raised to 220 GBp from 210 GBp at UBS
07/29/21 Deutsche Bank
Barclays price target raised to 240 GBp from 230 GBp at Deutsche Bank
07/29/21 Societe Generale
Barclays price target raised to 180 GBp from 170 GBp at Societe Generale
BAC Bank of America
$38.35 /

-0.335 (-0.87%)

07/19/21 Odeon Capital
Bank of America downgraded to Hold from Buy at Odeon Capital
07/06/21 Keefe Bruyette
Bank of America assumed with a Market Perform at Keefe Bruyette
06/02/21 Truist
Bank of America initiated with a Buy at Truist
05/04/21
Fly Intel: Top five analyst downgrades
BLK BlackRock
$867.23 /

-1.6 (-0.18%)

07/15/21 Credit Suisse
BlackRock price target lowered to $1,000 from $1,011 at Credit Suisse
07/15/21 Argus
BlackRock price target raised to $975 from $950 at Argus
07/15/21 Deutsche Bank
BlackRock price target lowered to $1,001 from $1,018 at Deutsche Bank
07/15/21 BMO Capital
BlackRock price target raised to $803 from $773 at BMO Capital
SPG Simon Property
$126.52 /

+0.63 (+0.50%)

07/19/21 Stifel
Simon Property upgraded to Buy from Hold at Stifel
06/28/21 Scotiabank
Simon Property price target raised to $138 from $117 at Scotiabank
06/22/21 Truist
Simon Property price target raised to $130 from $102 at Truist
06/21/21 Stifel
Simon Property price target raised to $125 from $120 at Stifel
SPG Simon Property
$126.52 /

+0.63 (+0.50%)

MS Morgan Stanley
$95.97 /

-0.295 (-0.31%)

GS Goldman Sachs
$375.04 /

-2.43 (-0.64%)

BLK BlackRock
$867.23 /

-1.6 (-0.18%)

BCS Barclays
$9.78 /

-0.18 (-1.81%)

BAC Bank of America
$38.35 /

-0.335 (-0.87%)

  • 30
    Jul
  • 30
    Jul
  • 30
    Jul
  • 30
    Jul
  • 29
    Jul
  • 30
    Jul
  • 30
    Jul
  • 29
    Jul
  • 30
    Jul
  • 29
    Jul
  • 29
    Jul
  • 28
    Jul
  • 28
    Jul
  • 30
    Jul
  • 28
    Jul
  • 29
    Jul
  • 29
    Jul
  • 27
    Jul
  • 14
    Jul
  • 16
    Jul
  • 08
    Jul
  • 08
    Jul
  • 08
    Jul
  • 19
    Nov
  • 13
    Nov
MS Morgan Stanley
$95.97 /

-0.295 (-0.31%)

HOOD Robinhood
$35.57 /

+0.75 (+2.15%)

GS Goldman Sachs
$375.04 /

-2.43 (-0.64%)

DUOL Duolingo
$140.08 /

+3.13 (+2.29%)

DOLE Dole
$14.55 /

-0.65 (-4.28%)

BLK BlackRock
$867.23 /

-1.6 (-0.18%)

BCS Barclays
$9.78 /

-0.18 (-1.81%)

AUTH Authentic Brands Group
$8.01 /

+ (+0.00%)

SPRK Spark Education
/

+

SPG Simon Property
$126.52 /

+0.63 (+0.50%)

RXST RxSight
$16.42 /

-1.33 (-7.49%)

MS Morgan Stanley
$95.97 /

-0.295 (-0.31%)

HOOD Robinhood
$35.57 /

+0.75 (+2.15%)

GS Goldman Sachs
$375.04 /

-2.43 (-0.64%)

DUOL Duolingo
$140.08 /

+3.13 (+2.29%)

BLK BlackRock
$867.23 /

-1.6 (-0.18%)

BCS Barclays
$9.78 /

-0.18 (-1.81%)

BAC Bank of America
$38.35 /

-0.335 (-0.87%)

AUTH Authentic Brands Group
$8.01 /

+ (+0.00%)

SPG Simon Property
$126.52 /

+0.63 (+0.50%)

MS Morgan Stanley
$95.97 /

-0.295 (-0.31%)

GS Goldman Sachs
$375.04 /

-2.43 (-0.64%)

BAC Bank of America
$38.35 /

-0.335 (-0.87%)

Syndicate
In8bio opens at $10, IPO priced at $10 » 11:37
07/30/21
07/30
11:37
07/30/21
11:37
INAB

In8bio

/

+

In8bio (INAB) priced 4M…

In8bio (INAB) priced 4M shares at $10.00. The deal range was $10.00-$12.00. B. Riley acted as sole book running manager for the offering. In8bio is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies utilizing its DeltEx platform.

ShowHide Related Items >><<
  • 30
    Jul
  • 13
    Nov
Syndicate
In8bio 4M share IPO priced at $10.00 » 07:05
07/30/21
07/30
07:05
07/30/21
07:05
INAB

In8bio

/

+

The deal range was…

The deal range was $10.00-$12.00. B. Riley acted as sole book running manager for the offering.

ShowHide Related Items >><<
  • 30
    Jul
  • 13
    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.